跳至主要内容
MedPath Trial Home
临床试验
产品
机构
资讯
AI 研究
价格
Search
EN
登录
我们重视您的隐私
我们使用 Cookie 分析网站流量并改善您的体验。请参阅我们的
隐私政策
。
拒绝
接受
找到 3,241 条关于
“RenLite”
全部
3,241
临床试验
3,178
药物
1
机构
6
资讯
56
9个月前
FDA Clears First-in-Class Bispecific ADC IDE034 for Phase 1 Trial in Multiple Solid Tumors
2年前
Bispecific Antibody-Drug Conjugates Show Promise in Solid Tumor Treatment
8个月前
Biocytogen and Acepodia Expand Partnership for Next-Generation Dual-Payload Bispecific ADCs
6个月前
Biocytogen Reaches Clinical Milestone as First Patient Dosed in IDEAYA's B7H3/PTK7 Bispecific ADC Phase 1 Trial
去年
IDEAYA Biosciences Licenses Biocytogen's B7H3/PTK7 Bispecific ADC for Solid Tumors
去年
IDEAYA Nominates IDE034, a First-in-Class B7H3/PTK7 Bispecific ADC, as Development Candidate
去年
IDEAYA Nominates IDE034, a First-in-Class B7H3/PTK7 Bispecific ADC, as Development Candidate
6个月前
Biocytogen Partners with Moonlight Bio to Develop Advanced Cell Therapies for Difficult-to-Treat Cancers
去年
Biocytogen Secures Japan Patent for RenMab Platform, Strengthening Global IP Portfolio for Fully Human Antibody Discovery
2个月前
Transgenic Animal Model Market Poised to Reach $6.79 Billion by 2035, Driven by CRISPR and Precision Medicine
第 1 页,共 6 页
上一页
下一页